QHQi He

Qi He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qi He has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Bingxuan Zheng

    Department of Kidney Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    2 shared publications
  • Chenguang Ding

    Department of Kidney Transplantation, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    2 shared publications
  • Shirui Sun

    Department of Kidney Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    2 shared publications
  • Yingcong Guo

    Department of Kidney Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    2 shared publications
  • Zepeng Li

    Department of Kidney Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    2 shared publications
  • Zhenting Zhao

    Department of Kidney Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    2 shared publications

Latest Publications

  • Open Access

    Chronic kidney disease in Asia: a meta-analysis

    by Guozhen Chen, Shirui Sun, Yingcong Guo, Qi He, Zepeng Li, Zhenting Zhao, Bingxuan Zheng, Haiping Liu, Wujun Xue, Chenguang Ding

    The prevalence of chronic kidney disease (CKD) in Asia was determined by comparing differences in age, sex, area, and analytical methods. This meta-analysis comprised 42 studies with 2,271,169 participants from five databases that were searched until February 30, 2025. The total prevalence of CKD 1-5 was 17.0%, whereas that of stages 3-5 was 7.7% in Asia. Individuals aged >60 years had a higher prevalence rate of CKD 1-5 compared to those aged <60 years. Compared with Asia (as the comparator), the age-standardized prevalence of CKD (aCKD) 1-5 was the highest in Nepal and South Asia, whereas it was the lowest in Vietnam. Compared with the comparator, Vietnam and Malaysia had the highest aCKD 3-5; while, South Korea and India had lower aCKD 3-5. The sex-standardized prevalence of CKD (sCKD) 1-5 was lower in Nepal, Taiwan, Korea, and South Asia and was higher in Bangladesh than in the comparator. The sCKD 3-5 was lowest in Korea and Taiwan and was highest in Iran and Sri Lanka compared with the comparator. Iranian women and men had the highest prevalence of CKD 3-5. South Asia has a higher prevalence of CKD among men and women than East Asia. The prevalence of CKD was greater in the Chronic Kidney Disease Epidemiology Collaboration-based studies than in the Modification of Diet in Renal Disease (MDRD)-based research. The findings indicate that evaluating populations without considering sex and age is difficult, especially when the sex and age of the groups differ greatly.


  • METTL3 promotes renal ischemia‐reperfusion injury by modulating miR ‐374b‐5p/ SRSF7 axis

    by Kun Zhu, Shirui Sun, Zepeng Li, Ge Deng, Yingcong Guo, Bingxuan Zheng, Qi He, Zhenting Zhao, Chenguang Ding

    Renal ischemia–reperfusion injury (IRI) is a prevalent cause of acute kidney injury, however, the regulatory mechanisms of miR‐374b‐5p in renal IRI remain poorly understood. We established hypoxia/reoxidation (H/R)‐induced renal injury models using HK‐2 and TCMK‐1 cells, as well as an ischemia–reperfusion (I/R)‐induced mouse model. Renal tubular epithelial cells (RTECs) viability and apoptosis were assessed using CCK‐8, flow cytometry, and TUNEL assays. The targeting relationship between miR‐374b‐5p and SRSF7 was analyzed using dual luciferase reporter assays. The interaction between METTL3 and miR‐374b‐5p was confirmed through methylated RNA immunoprecipitation (MeRIP) and co‐immunoprecipitation (Co‐IP) assays. We found that miR‐374b‐5p levels were significantly upregulated in H/R‐induced HK‐2 and TCMK‐1 cells. Furthermore, miR‐374b‐5p promoted H/R‐induced RTEC injury by suppressing cell viability and exacerbating apoptosis. SRSF7 was identified as a downstream target of miR‐374b‐5p, inhibition of SRSF7 reversed the inhibitory effects of miR‐374b‐5p inhibitors on RTEC injury. Additionally, METTL3 interacted with the microprocessor protein DGCR8 and modulated the processing of pri‐miR‐374b‐5p in an m6A‐dependent manner. In the renal IRI model, METTL3 and miR‐374b‐5p levels were upregulated, and knockdown of METTL3 inhibited apoptosis in H/R‐induced HK‐2 and TCMK‐1 cells. Conversely, miR‐374b‐5p reversed the protective effects of METTL3 knockdown on renal IRI. Our findings provide novel insights into the role of m6A methylation in the development of renal IRI, demonstrating that METTL3 promotes renal IRI by modulating the miR‐374b‐5p/ SRSF7 axis.